ISRCTN62416244已完成不适用
Study of Tolerance to Oral Peanut: a randomised controlled trial of oral peanut immunotherapy
Addenbrooke's Hospital (UK)0 个研究点目标入组 104 人开始时间: 2010年4月29日最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Aged greater than 7 years, either sex
- •2. Peanut allergy defined as a clear history of a typical immediate reaction following definite peanut ingestion
排除标准
- •Major immunodeficiency (this will influence outcome)
研究者
相似试验
进行中（未招募）
1 期
Peanut Allergy StudyPeanut AllergyEUCTR2021-002533-42-Outside-EU/EEAAimmune Therapeutics, Inc.
进行中（未招募）
不适用
Oral peanut immunotherapy with a modified dietary starch adjuvant for treatment of peanut allergy in children aged 10-16 years.Peanut allergyInflammatory and Immune System - AllergiesACTRN12617000914369Sydney Children's Hospital Network65
已完成
2 期
The Peanut Oral Immunotherapy Study: Safety, Efficacy and DiscoveryPeanut AllergyNCT02103270Stanford University120
进行中（未招募）
不适用
Peanut and Tree Nut DesensitizationPeanut AllergyTree Nut AllergyNCT03532360McGill University Health Centre/Research Institute of the McGill University Health Centre51
已完成
不适用
Peanut sensitization, the relationship with peanut-related symptoms and asthma in childrehypersensitivity reactionintolerance1000170810006436NL-OMON35756Isala Klinieken425